Quantitative DNA values in bronchogenic carcinoma.

R L Teplitz; L R Hill

Home/Archive/PubMed

PubMed · 6465699

Quantitative DNA values in bronchogenic carcinoma.

R L Teplitz·L R Hill

View original source ↗Export metadata ↓

Abstract

Quantitative DNA analysis of neoplastic cells often produces standard deviations that are nonsymmetrical; attempts at correcting this characteristic by mathematical means have been only partially successful. We examined the sources of the skewed values and the appropriate means for their "correction." The analysis showed that the deviation from symmetry lies within several biologic parameters. These deviations from symmetry may, therefore, teach something of value regarding the biologic process under study instead of requiring the application of arbitrary "corrections."

Explore related subjects

Carcinoma, Bronchogenic Cell Cycle Cell Nucleus DNA Evaluation Studies as Topic Humans Lung Neoplasms Statistics as Topic Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

R L Teplitz, L R Hill. 1984. Quantitative DNA values in bronchogenic carcinoma.. https://pubmed.ncbi.nlm.nih.gov/6465699/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Transthoracic esophagectomy and lobectomy performed in a patient with synchronous lung cancer and combined esophageal cancer and esophageal leiomyosarcoma.

We report a pitfall deriving from the assumption of metastatic disease based upon seemingly identical histology in a pulmonary lesion and in the esophagus. In a 60-year-old patient, cT1 esophageal squamous cell carcinoma was found. One of the two pulmonary nodules was histologically diagnosed as metastasis. When esophageal perforation occurred during palliative therapy, esophagectomy became necessary together with the right lower lobectomy for the removal of the remaining pulmonary lesion. Definitive histology showed pT1N0 cancer of the esophagus, primary esophageal sarcoma and pT4N0 bronchogenic carcinoma. The other pulmonary lesion was re-evaluated and defined as intralobar M1 of bronchogenic carcinoma.

Carcinoma, Bronchogenic↗

PubMed2006

Acrokeratosis paraneoplastica (Bazex syndrome): case report and review of literature.

Acrokeratosis paraneoplastica of Bazex is a rare syndrome. This condition is a distinct skin marker of supra-diaphragmatic neoplasia. This syndrome is important because the cutaneous findings preceed the onset of symptoms referable to the underlying neoplasm by several months in majority of the cases. We report here a case of a 63-year-old cachectic female who had classic psoriasiform lesions of acrokeratosis of Bazex with underlying bronchogenic carcinoma of the right lung.

Carcinoma, Bronchogenic↗

PubMed2006

Minimally invasive pneumonectomy.

Technical advances have resulted in the growing popularity and success of video-assisted thoracoscopic lobectomy for the treatment of nonsmall cell lung cancer. Several investigators have used similar techniques to safely perform pneumonectomies. Minimally invasive pneumonectomy may be indicated for patients who have centrally located malignant lesions and who are not candidates for sleeve resections. Adequate exposure of the proximal hilar vessels is mandatory. Short-term results are encouraging, but prospective long-term data are essential.

Carcinoma, Bronchogenic↗